Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-05-19 @ 1:57 PM
Study NCT ID:
NCT01182194
Status:
COMPLETED
Last Update Posted:
2010-12-08
First Post:
2010-08-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R06-0631
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None